ReviewPharmaceuticals (Basel, Switzerland)2025

Efficacy of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Moderate-to-Severe COPD Exacerbations Among Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.

Edoardo Pirera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.